skip to main content

News Archive

Date: 01/10/2023
Anao Zhang, Ph.D., LCSW, ACSW, ACBT is principal investigator on a new project funded with a $250,000 Eugene Washington PCORI Engagement Award, an initiative of the Patient-Centered Outcomes Research Institute, or PCORI. The research team will build out existing research infrastructure in patient-centered outcomes to enhance participation from AYA cancer survivors who identify as BIPOC or sexual and gender minorities.
Date: 12/07/2022
Rogel Cancer Center faculty and trainees will lead more than two dozen presentations, posters and moderated sessions at the American Society of Hematology annual meeting. This year’s meeting will be held in-person and virtually.
Date: 12/06/2022
Principal investigator Arul Chinnaiyan, M.D., Ph.D., will lead a $4 million project that will employ a suite of cutting-edge drug development techniques to develop an effective inhibitor of MYC, a major driver of about 70% of all cancers, including prostate cancer.
Date: 11/18/2022
As part of its Discovery Science grants program, the American Cancer Society has awarded Rogel Cancer Center researcher Anthony Scott, M.D., $792,000 to look at how genes associated with Lynch syndrome impact cancer developing.
Date: 11/08/2022
The death rate for women with metastatic breast cancer is linked to the number of chronic health conditions they have, according to a study by the University of Michigan in partnership with the Kaiser Permanente Southern California Department of Research & Evaluation.
Date: 10/25/2022
In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a large, longitudinal analysis found Veterans Health Administration (VA) medical centers with lower prostate screening rates had higher rates of metastatic prostate cancer cases in subsequent years than centers with higher screening rates.
Date: 10/24/2022
A new study, presented at the annual ASTRO meeting, finds that sexual side effects of cancer treatment are discussed far less frequently with female patients than with male patients, even when the treatment directly affects sex organs.
Date: 10/13/2022
An international team of researchers led by the University of Michigan Rogel Cancer Center received a collaborative grant from the National Cancer Institute with a goal of bringing new insights into leiomyosarcoma, a rare form of cancer that seemingly originates in smooth muscle. The grant, worth $12.3 million, is through the NCI’s SPORE, or Specialized Program of Research Excellence, which funds collaborative, interdisciplinary translational cancer research.
Date: 10/12/2022
Rogel Cancer Center faculty and trainees will lead 30 presentations, posters and moderated sessions at the American Society of Radiation Oncology annual meeting. This year’s meeting will be held in-person, virtually and on-demand.
Date: 10/05/2022
Friends, faculty and staff of the Rogel Cancer Center gathered amidst a rainbow of lights, ribbons and balloons on Sept. 23 to raise money for cancer research.

Pages